Member Info for Matador78

Directly from Rebekah

Or CuraLeaf

2 Weeks till South West Brand Launches

Seed Innovations could well be a nursery greenhouse for CuraLeaf.

Boris Jordan may well provide the 5-10-15% sticky foundations holdings which Ed is looking for

Same thing will happen as last time, There'll be a short delay then a raft of buying

https://jerseyeveningpost.com/news/2021/08/05/cannabis-trade-body-launched/

Prostophane (Sufurophane compound is excellent in this respect. There's a french firm that produce it at the moment. Otherwise the long way round is Broccoli sprouts.

Never Rush into an RNS

With the local range of medical cannabis, one is mainly used to the names on the supplier side that one also knows from the view over the Atlantic. As a European company, Eurox Pharma relies on cannabis extracts Made in Germany to conquer the European market.

“We are a company anchored in Europe whose mission is to produce cannabis medicine of consistently high quality for our patients. We are building on our pharmaceutical know-how and a transparent European supply chain in order to guarantee a safe supply, ”explains founder and co-managing director Dr. Bernhard Babel.

For this purpose, Eurox Pharma maintains a production partnership with Dr. Reckeweg & Co. GmbH, which has over 75 years of experience in the manufacture of herbal medicinal products and which produces cannabis extracts according to the strict guidelines of good manufacturing practice (GMP). In the ultra-modern production facility in Bensheim, the cooperation partners not only meet pharmaceutical standards at the highest level, but also all legal requirements for working with cannabis flowers.

“Sustainability in production is an important part of our DNA. We use our expertise in processing in Germany, we source our flowers from selected partners in Spain and Canada and our own cultivation in Portugal will be completed in the fourth quarter of 2021. There we benefit from the advantages of the natural climate, ”emphasizes David Reckeweg-Lecompte, Co-Managing Director of Eurox Pharma.

The company's core business is supported by two further partnerships: On the one hand, the company maintains a scientific cooperation with the Institute for Pharmaceutical Biology at the Goethe University in Frankfurt am Main. Scientists there are currently researching the effectiveness of cannabis extracts for various indications.

Eurox Pharma also has a stake in the Integro Cannabis clinic in London. There, patients who have already undergone therapy are often advised by medical specialists at the highest level about possible therapy options in the field of cannabis medicine. Voluntary and anonymous surveys are carried out regularly among the patients. Further partnerships with German and European universities for basic research and possible clinical studies are planned.

Does Yooma work itself into an already saturated industry and carve out a name for itself or does it use its contacts and expertise to present itself as a takeover target for a more established Drinks Company.

Time will tell.

A coalition of consumer brands that includes Coca-Cola, PepsiCo and Kellogg is appealing to U.S. health regulators to get going on regulations to allow over-the-counter CBD.

The July 22 letter from the Consumer Brands Association argues that current U.S. policy on CBD “is not working” because CBD is not allowed in foods, drinks and dietary supplements, but such products are nonetheless commonly sold by companies flouting regulations from the U.S. Food and Drug Administration.

I wasn't surprised it was ignored in the least. For a start I wrote the post and so it is ignored by most plus then comes the fact that the people who frequent this board are literally just trying to swing trades between 10 to 20% before they dive off to another stock.

Thanks for bringing it up. : )

I'm sat at my office during the day and so post as and when something interests me.

At home I can read through the posts at leisure and spend more time on research. My research on SAR is lacklustre I'm the first to admit. I find most of the factual technical information slightly boggling even though I have an eye for science and biology.

I prefer bullet points and laymans when it comes to SAR

And do you're own thing

You're turning into a board of screaming Marys

I think the 5 Million strategic investor if not a HNW individual will likely be Chrystal Capital who share an office with some interesting folk.

Likely something to do with the Verdite fund.

What’s Inveniam worth?

Tic Tacs in a wheelie bin..

Where the hell did that come from?

Laughing my head off here

Did somebody say Bull?

that went well

Which is exactly my point Baldy. I've been loading up while I've been quiet.